Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the Mouth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00251433
What this trial is testing

GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast Cancer

Who this might be right for
Neoplasms, Breast
Novartis Pharmaceuticals 53
Not applicableStudy completedNCT00897052
What this trial is testing

Gene Expression Profiles in Predicting Survival of Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 29
Not applicableStudy completedNCT00002026
What this trial is testing

Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)

Who this might be right for
Leukoplakia, HairyHIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)Ended earlyNCT01192815
What this trial is testing

Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck

Who this might be right for
Stage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the LarynxStage III Squamous Cell Carcinoma of the Lip and Oral Cavity+9 more
Case Comprehensive Cancer Center 2
Early research (Phase 1)Active Not RecruitingNCT03807778
What this trial is testing

Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Takeda 53
Testing effectiveness (Phase 2)Study completedNCT00721799
What this trial is testing

F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients

Who this might be right for
Mouth NeoplasmsOropharyngeal NeoplasmsLaryngeal Neoplasms+1 more
University of Iowa 33
Early research (Phase 1)Ended earlyNCT06264921
What this trial is testing

A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorSolid Tumor, AdultAdvanced Solid Tumor+26 more
NiKang Therapeutics, Inc. 23
Not applicableUnknownNCT04742998
What this trial is testing

Task of Acoustic-phonetic Decoding on Anatomic Deficits in Paramedical Assessment of Speech Disorders for Patients Treated for Oral or Oropharyngeal Cancer

Who this might be right for
Speech Intelligibility
University Hospital, Toulouse 116
Early research (Phase 1)Looking for participantsNCT06868433
What this trial is testing

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+20 more
Emory University
Not applicableUnknownNCT03776578
What this trial is testing

Oral Cancer With Wide Excision and Free Flap Reconstruction

Who this might be right for
Head and Neck Cancer
National Taiwan University Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00099021
What this trial is testing

Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

Who this might be right for
Head and Neck CancerOral Leukoplakia
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07032532
What this trial is testing

Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23)

Who this might be right for
Peripheral T Cell Lymphoma
Sun Yat-sen University 35
Testing effectiveness (Phase 2)Study completedNCT00005814
What this trial is testing

Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Memorial Sloan Kettering Cancer Center
Not applicableEnded earlyNCT03862066
What this trial is testing

Memory Phenotype and PD-1 Inhibition Response in Oral Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Medical University of South Carolina 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT05010629
What this trial is testing

9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma

Who this might be right for
Salivary Gland CancerRecurrent Salivary Gland CancerMetastatic Cancer+1 more
Glenn J. Hanna 32
Early research (Phase 1)Looking for participantsNCT06673329
What this trial is testing

Brodalumab in the Treatment of Immune-Related Adverse Events

Who this might be right for
Breast CancerEsophageal CancerKidney Cancer+15 more
Brian Henick, MD 11
Not applicableLooking for participantsNCT02584270
What this trial is testing

Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue

Who this might be right for
Tongue NeoplasmsTongue CancerOral Cancer
University of Michigan 40
Large-scale testing (Phase 3)Ended earlyNCT00236002
What this trial is testing

Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )

Who this might be right for
Osteoporosis
Canadian Urology Research Consortium 182
Early research (Phase 1)Study completedNCT03672695
What this trial is testing

Phase I Dose Escalation Study of Intravenously Administered S64315 in Combination With Orally Administered Venetoclax in Patients With Acute Myeloid Leukaemia.

Who this might be right for
Acute Myeloid Leukaemia
Institut de Recherches Internationales Servier 37
Early research (Phase 1)Looking for participantsNCT06813365
What this trial is testing

Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN2)

Who this might be right for
Nonsmall-cell Lung Cancer
Dizal Pharmaceuticals 300
Next Page
40